Benzinga | Jul 19, 2021 09:45AM EDT

Goldman Sachs Maintains Buy on HCA Healthcare, Raises Price Target to $252

Goldman Sachs analyst Jamie Perse maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $223 to $252.